$20.51
▲ +1.4% Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
Janux Therapeutics (JANX) Is Up 7.1% After Reporting Narrower Net Losses And Improved Earnings Profile
RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates
Overview
52-week range
$12
$35
36% of range
Avg surprise (last 3)
+6.4%
Avg reaction (last 2)
+1.0%
50% positive
Latest IV / EM
76%
EM ±11.9% · $20 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.35 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.39 | $-0.50 | +22.0% | -2.6% | -0.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.39 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.55 | $-0.48 | -14.6% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.38 | $-0.43 | +11.6% | — | +2.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.51 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.11 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.30 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.25 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.42 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.42 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | — | $10M | $0 | $0 | — | $439,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-32M | $-34M | — | $-35M | $-45M | $-35M | — | $-36M |
| Net income | $-22M | $-24M | — | $-24M | $-34M | $-24M | — | $-28M |
| EPS (diluted) | $-0.35 | $-0.39 | — | $-0.39 | $-0.55 | $-0.38 | — | $-0.51 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $28M | $52M | $52M | $48M | $52M | $74M | $431M | $27M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $983M | $1.00B | $976M | $998M | $1.01B | $1.02B | $1.03B | $666M |
| Total assets | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $80M | $87M | $45M | $48M | $42M | $38M | $39M | $39M |
| Total equity | $928M | $942M | $957M | $977M | $991M | $1.01B | $1.02B | $656M |